The US IPO market slowed this week with four small companies raising less than $100 million in their deals and seeing lukewarm receptions from IPO investors. Biotechs Zogenix (ZGNX) and...read more
SYSWIN, a leading provider of real estate agency services to property developers in Beijing, raised $67 million by selling 9.6 million ADSs at $7, well below its originally anticipated terms of 12 million ADSs at a price of $9.25 to $11.25. Earlier on Tuesday,...read more
Zogenix, which recently launched Sumavel DosePro, a needle-free injectable migraine treatment, raised $56 million by offering 14 million shares (versus 6 million shares as originally planned) at $4, a sharp 69% discount to its proposed range of $12 to $14. ...read more
US IPO market slows pace in shortened holiday week with four tepid debuts
The US IPO market slowed this week with four small companies raising less than $100 million in their deals and seeing lukewarm receptions from IPO investors. Biotechs Zogenix (ZGNX) and...read more
Chinese real estate agency services provider SYSWIN prices IPO at $7 per ADS; raises $67 million
SYSWIN, a leading provider of real estate agency services to property developers in Beijing, raised $67 million by selling 9.6 million ADSs at $7, well below its originally anticipated terms of 12 million ADSs at a price of $9.25 to $11.25. Earlier on Tuesday,...read more
Zogenix prices IPO at $4, raises $56 million to fund drug development
Zogenix, which recently launched Sumavel DosePro, a needle-free injectable migraine treatment, raised $56 million by offering 14 million shares (versus 6 million shares as originally planned) at $4, a sharp 69% discount to its proposed range of $12 to $14. ...read more
4 IPOs planned for the week of Nov 22
The following IPOs are expected to price this week:
Anacor Pharmaceuticals (ANAC), which is developing treatments for nail fungus and psoriasis using boron-based chemistry,...read more